Tumour suppressors: A microdependency of importance?
14:51 EDT 30 Aug 2012 | Nature Publishing
A new study suggests a therapeutic strategy to target retinoblastomas that are deficient for RB and p53.
Original Article: Tumour suppressors: A microdependency of importance?
More From BioPortfolio on "Tumour suppressors: A microdependency of importance?"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
